Anderson M S, Bulawa C E, Raetz C R
J Biol Chem. 1985 Dec 15;260(29):15536-41.
The Gram-negative bacterium Escherichia coli has previously been shown to utilize two unique glucosamine (GlcN)-derived phospholipids in the biosynthesis of lipid A disaccharides (Bulawa, C.E., and Raetz, C. R.H. (1984) J. Biol. Chem. 259, 4846-4851; Ray, B. L., Painter, G.L., and Raetz, C.R.H. (1984) J. Biol. Chem. 259, 4852-4859. We now present evidence that these compounds, UDP-2,3-diacyl-GlcN and 2,3-diacyl-GlcN-1-phosphate (2,3-diacyl-GlcN-1-P), are generated in extracts of E. coli by fatty acylation of UDP-GlcNAc. The initial reaction is an O-acylation of the glucosamine ring, presumably of the 3-OH group, with (R)-beta-hydroxymyristate, followed by removal of the acetyl moiety, and further fatty acylation of the N atom with (R)-beta-hydroxymyristate to yield UDP-2,3-diacyl-GlcN. Hydrolysis of the pyrophosphate bridge in this molecule gives 2,3-diacyl-GlcN-1-P + UMP. In vivo pulse labeling with 32Pi supports this postulated pathway, since UDP-2,3-diacyl-GlcN is labeled prior to 2,3-diacyl-GlcN-1-P. UDP-glucosamine is inactive as a substrate in the initial acylation reaction. These acylations show an absolute specificity for fatty acyl moieties activated with acyl carrier protein. No reaction is detected with fatty acyl-CoA or free fatty acid. The fatty acylation of sugar nucleotides has not been reported previously in E. coli or any other organism.
革兰氏阴性菌大肠杆菌先前已被证明在脂多糖A二糖的生物合成中利用两种独特的源自氨基葡萄糖(GlcN)的磷脂(布拉瓦,C.E.,和雷茨,C.R.H.(1984年)《生物化学杂志》259卷,4846 - 4851页;雷,B.L.,佩因特,G.L.,和雷茨,C.R.H.(1984年)《生物化学杂志》259卷,4852 - 4859页)。我们现在提供证据表明,这些化合物,UDP - 2,3 - 二酰基 - GlcN和2,3 - 二酰基 - GlcN - 1 - 磷酸(2,3 - 二酰基 - GlcN - 1 - P),是通过大肠杆菌提取物中UDP - GlcNAc的脂肪酰化反应生成的。初始反应是氨基葡萄糖环的O - 酰化,大概是3 - OH基团与(R) - β - 羟基肉豆蔻酸发生反应,随后去除乙酰基部分,然后N原子再与(R) - β - 羟基肉豆蔻酸进行进一步的脂肪酰化反应,生成UDP - 2,3 - 二酰基 - GlcN。该分子中焦磷酸桥的水解产生2,3 - 二酰基 - GlcN - 1 - P + UMP。用32Pi进行体内脉冲标记支持了这一假定途径,因为UDP - 2,3 - 二酰基 - GlcN在2,3 - 二酰基 - GlcN - 1 - P之前被标记。UDP - 葡萄糖胺在初始酰化反应中作为底物无活性。这些酰化反应对与酰基载体蛋白活化的脂肪酰基部分表现出绝对特异性。未检测到与脂肪酰辅酶A或游离脂肪酸的反应。糖核苷酸的脂肪酰化反应此前在大肠杆菌或任何其他生物体中均未被报道。